UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 249

Sortiert nach

Use of direct oral anticoagulants in patients with obesity for treatment and prevention of venous thromboembolism: Updated communication from the ISTH SSC Subcommittee on Control of Anticoagulation

Journal of thrombosis and haemostasis, 2021-08, Vol.19 (8), p.1874-1882

2021

Link zum Volltext

Verfügbarkeit prüfen

Definition of haemostatic effectiveness in interventions used to treat major bleeding: Communication from the ISTH SSC Subcommittee on Control of Anticoagulation

Journal of thrombosis and haemostasis, 2021-04, Vol.19 (4), p.1112-1115

2021

Link zum Volltext

Verfügbarkeit prüfen

Definition of major bleeding: Prognostic classification

Journal of thrombosis and haemostasis, 2020-11, Vol.18 (11), p.2852-2860

2020

Link zum Volltext

Verfügbarkeit prüfen

Clinical history of cancer‐associated splanchnic vein thrombosis

Journal of thrombosis and haemostasis, 2021-04, Vol.19 (4), p.983-991

2021

Link zum Volltext

Verfügbarkeit prüfen

Effectiveness and safety of rivaroxaban and warfarin for prevention of major adverse cardiovascular or limb events in patients with non‐valvular atrial fibrillation and type 2 diabetes

Diabetes, obesity & metabolism, 2019-09, Vol.21 (9), p.2107-2114

2019

Link zum Volltext

Verfügbarkeit prüfen

Method agreement analysis and interobserver reliability of the ISTH proposed definitions for effective hemostasis in management of major bleeding

Journal of thrombosis and haemostasis, 2019-03, Vol.17 (3), p.499-506

2019

Link zum Volltext

Verfügbarkeit prüfen

Reply: Method agreement analysis and interobserver reliability of the ISTH proposed definitions for effective hemostasis in the management of major bleeding: Methodological issues

Journal of thrombosis and haemostasis, 2019-08, Vol.17 (8), p.1398-1399

2019

Link zum Volltext

Verfügbarkeit prüfen

Reproductive issues in women on direct oral anticoagulants

Research and practice in thrombosis and haemostasis, 2021-05, Vol.5 (4), p.e12512-n/a, Article e12512

2021

Link zum Volltext

Verfügbarkeit prüfen

What have we learned from real-world NOAC studies in venous thromboembolism treatment?

Thrombosis research, 2018-03, Vol.163, p.83-91

Beyer-Westendorf, Jan

2018

Link zum Volltext

Verfügbarkeit prüfen

Comparative risk of major bleeding with rivaroxaban and warfarin: Population‐based cohort study of unprovoked venous thromboembolism

European journal of haematology, 2019-02, Vol.102 (2), p.143-149

2019

Link zum Volltext

Verfügbarkeit prüfen

Anticoagulant therapy for splanchnic vein thrombosis: ISTH SSC Subcommittee Control of Anticoagulation

Journal of thrombosis and haemostasis, 2020-07, Vol.18 (7), p.1562-1568

2020

Link zum Volltext

Verfügbarkeit prüfen

The prognostic value of respiratory symptoms and performance status in ambulatory cancer patients and unsuspected pulmonary embolism; analysis of an international, prospective, observational cohort study

Journal of thrombosis and haemostasis, 2021-11, Vol.19 (11), p.2791-2800

2021

Link zum Volltext

Verfügbarkeit prüfen

Exposure to vitamin k antagonists and kidney function decline in patients with atrial fibrillation and chronic kidney disease

Research and practice in thrombosis and haemostasis, 2019-04, Vol.3 (2), p.207-216

2019

Link zum Volltext

Verfügbarkeit prüfen

Anticoagulant therapy for splanchnic vein thrombosis: an individual patient data meta-analysis

Blood advances, 2022-08, Vol.6 (15), p.4516-4523

2022

Link zum Volltext

Verfügbarkeit prüfen

Rates, management, and outcome of rivaroxaban bleeding in daily care: results from the Dresden NOAC registry

Blood, 2014-08, Vol.124 (6), p.955-962

2014

Link zum Volltext

Verfügbarkeit prüfen

Predictors of Intracranial Hemorrhage Volume Expansion in Patients Receiving Factor Xa Inhibitors in ANNEXA‐4: Time and Severity Matter Most

Stroke: vascular and interventional neurology, 2024-01, Vol.4 (1)

2024

Link zum Volltext

Verfügbarkeit prüfen

Randomized, Controlled Trial of Ultrasound-Assisted Catheter-Directed Thrombolysis for Acute Intermediate-Risk Pulmonary Embolism

Circulation (New York, N.Y.), 2014-01, Vol.129 (4), p.479-486

2014

Link zum Volltext

Verfügbarkeit prüfen

Response to the Letter by Lucijanic et al., regarding our manuscript “Management and outcome of gastro-intestinal bleeding in patients taking oral anticoagulants or antiplatelet drugs”

Journal of gastroenterology, 2017-09, Vol.52 (9), p.1077-1078

Beyer-Westendorf, Jan

2017

Link zum Volltext

Verfügbarkeit prüfen

Pooled Analysis of Rivaroxaban therapy for acute venous thromboembolism in FIRST registry, SWIVTER and DRESDEN NOAC registry

Research and practice in thrombosis and haemostasis, 2022-10, Vol.6 (7), p.e12829-n/a, Article e12829

2022

Link zum Volltext

Verfügbarkeit prüfen

Cancer‐Associated ThrOmboSIs – Patient‐Reported OutcoMes With RivarOxaban (COSIMO) – Baseline characteristics and clinical outcomes

Research and practice in thrombosis and haemostasis, 2021-12, Vol.5 (8), p.e12604-n/a, Article e12604

2021

Link zum Volltext

Verfügbarkeit prüfen

Andexanet alfa versus four-factor prothrombin complex concentrate for the reversal of apixaban- or rivaroxaban-associated intracranial hemorrhage: a propensity score-overlap weighted analysis

Critical care (London, England), 2022-06, Vol.26 (1), p.180-13, Article 180

2022

Link zum Volltext

Verfügbarkeit prüfen

Clinical Impact of Bleeding in Cancer-Associated Venous Thromboembolism: Results from the Hokusai VTE Cancer Study

Thrombosis and haemostasis, 2018-08, Vol.118 (8), p.1439

2018

Link zum Volltext

Verfügbarkeit prüfen

Edoxaban in patients with non-valvular atrial fibrillation after percutaneous coronary intervention: ENCOURAGE-AF design

Scientific reports, 2023-10, Vol.13 (1), p.18215-18215, Article 18215

2023

Link zum Volltext

Verfügbarkeit prüfen

Heavy menstrual bleeding in women on anticoagulant treatment for venous thromboembolism: Comparison of high‐ and low‐dose rivaroxaban with aspirin

Research and practice in thrombosis and haemostasis, 2021-02, Vol.5 (2), p.308-313

2021

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 249

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(235)
Mit Volltextzugriff
(207)

Publikationsform

Artikel
(247)
Bücher
(1)
Berichte
(1)

Sprache

Englisch
(239)
Deutsch
(12)
Japanisch
(11)
Norwegisch
(2)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

Menü

Weitere Dienste

Einstellungen

Use of direct oral anticoagulants in patients with obesity for treatment and prevention of venous thromboembolism: Updated communication from the ISTH SSC Subcommittee on Control of Anticoagulation

Definition of haemostatic effectiveness in interventions used to treat major bleeding: Communication from the ISTH SSC Subcommittee on Control of Anticoagulation

Definition of major bleeding: Prognostic classification

Clinical history of cancer‐associated splanchnic vein thrombosis

Effectiveness and safety of rivaroxaban and warfarin for prevention of major adverse cardiovascular or limb events in patients with non‐valvular atrial fibrillation and type 2 diabetes

Method agreement analysis and interobserver reliability of the ISTH proposed definitions for effective hemostasis in management of major bleeding

Reply: Method agreement analysis and interobserver reliability of the ISTH proposed definitions for effective hemostasis in the management of major bleeding: Methodological issues

Reproductive issues in women on direct oral anticoagulants

What have we learned from real-world NOAC studies in venous thromboembolism treatment?

Comparative risk of major bleeding with rivaroxaban and warfarin: Population‐based cohort study of unprovoked venous thromboembolism

Anticoagulant therapy for splanchnic vein thrombosis: ISTH SSC Subcommittee Control of Anticoagulation

The prognostic value of respiratory symptoms and performance status in ambulatory cancer patients and unsuspected pulmonary embolism; analysis of an international, prospective, observational cohort study

Exposure to vitamin k antagonists and kidney function decline in patients with atrial fibrillation and chronic kidney disease

Rivaroxaban for the treatment of noncirrhotic splanchnic vein thrombosis: an interventional prospective cohort study

Anticoagulant therapy for splanchnic vein thrombosis: an individual patient data meta-analysis

Rates, management, and outcome of rivaroxaban bleeding in daily care: results from the Dresden NOAC registry

Predictors of Intracranial Hemorrhage Volume Expansion in Patients Receiving Factor Xa Inhibitors in ANNEXA‐4: Time and Severity Matter Most

Randomized, Controlled Trial of Ultrasound-Assisted Catheter-Directed Thrombolysis for Acute Intermediate-Risk Pulmonary Embolism

Response to the Letter by Lucijanic et al., regarding our manuscript “Management and outcome of gastro-intestinal bleeding in patients taking oral anticoagulants or antiplatelet drugs”

Pooled Analysis of Rivaroxaban therapy for acute venous thromboembolism in FIRST registry, SWIVTER and DRESDEN NOAC registry

Cancer‐Associated ThrOmboSIs – Patient‐Reported OutcoMes With RivarOxaban (COSIMO) – Baseline characteristics and clinical outcomes

Andexanet alfa versus four-factor prothrombin complex concentrate for the reversal of apixaban- or rivaroxaban-associated intracranial hemorrhage: a propensity score-overlap weighted analysis

Clinical Impact of Bleeding in Cancer-Associated Venous Thromboembolism: Results from the Hokusai VTE Cancer Study

Edoxaban in patients with non-valvular atrial fibrillation after percutaneous coronary intervention: ENCOURAGE-AF design

Heavy menstrual bleeding in women on anticoagulant treatment for venous thromboembolism: Comparison of high‐ and low‐dose rivaroxaban with aspirin

Suchergebnisse filtern